Not exact matches
«This technology [stereotactic body radiation] has been used successfully in both primary and metastatic
lung and liver
cancers, notably for
patients who could not otherwise
undergo surgery,
with local control rates in excess of 90 percent» says Gan.
Patients, especially those
with larger tumors, who
undergo thoracoscopic resections might have improved
cancer specific survival compared
with those
undergoing SABR for early stage non-small
lung cancer
Of the
patients undergoing SABR, 419 (58.7 %) died during follow - up,
with 119 (16.7 %) dying from
lung cancer; and 680 (30.1 %)
patients undergoing video assisted thoracoscopic resection died during follow - up,
with 198 (8.8 %) dying from
lung cancer.